MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Eledon Pharmaceuticals, Inc. Common Stock

ELDN

#3003
Eledon Pharmaceuticals, Inc. Common Stock
2.62
+10.08%
Sector:
Base:
Profit Currency:
Daily Range
2.62
2.62
Year Range
1.36
4.60
Daily Change
+10.08%
Monthly Change
+19.09%
6 month change
+1.55%
Year Change
-37.77%
Previous Close
2.38
Open
2.62
Bid
Ask
Low
2.62
High
2.62
Volume
55
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ELDN
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
ELDN
2026.02.12
Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path
Investing Investing
ELDN
2026.01.23
Eledon reports positive 24-month kidney transplant data for tegoprubart
Investing Investing
ELDN
2026.01.08
Eledon’s tegoprubart shows promise in kidney transplantation trials
Investing Investing
ELDN
2025.11.18
Eledon Pharmaceuticals stock rises after positive islet transplant data
Investing Investing
ELDN
2025.11.18
Eledon’s anti-CD40L antibody shows promise in diabetes trial
Investing Investing
ELDN
2025.11.18
Guggenheim lowers Eledon Pharmaceuticals stock price target on dilution
Seeking Alpha Seeking Alpha
ELDN
2025.11.17
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript
Investing Investing
ELDN
2025.11.12
Eledon Pharmaceuticals at Guggenheim Conference: Strategic Insights on Tegoprubart
Investing Investing
ELDN
2025.11.12
Eledon Pharmaceuticals stock drops after pricing $50M public offering
Investing Investing
ELDN
2025.11.12
Eledon prices $50 million public offering of stock and warrants
Investing Investing
ELDN
2025.11.11
Eledon Pharmaceuticals launches public offering of common stock
Investing Investing
ELDN
2025.11.10
Leerink Partners lowers Eledon Pharmaceuticals stock price target to $5 from $8

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd